NCT00762645View on ClinicalTrials.gov

Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Angle-closure Glaucoma
Interventions
DRUG

Travoprost 0.004% (Travatan)

One drop in each eye, once daily at 9 AM

DRUG

Pilocarpine 1%

One drop in each eye, forth times daily at 7 AM, 11 AM , 4 PM and 9 PM for twelve (12) weeks

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00762645 - Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG) | Biotech Hunter | Biotech Hunter